WNT11, WNT9A and WNT4 were tumor negative WNTs, which were abundant in normal tissues, while declining in many tumors including melanoma, sarcoma, breast adenocarcinoma and colorectal adenocarcinoma. This evidence concerns the gene WNT9A and sarcoma.